UK markets closed

Sanofi (SAN.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
86.47-0.20 (-0.23%)
At close: 05:36PM CEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
46,444,000
46,444,000
45,389,000
39,175,000
37,369,000
Cost of revenue
14,236,000
14,236,000
13,695,000
12,255,000
12,159,000
Gross profit
32,208,000
32,208,000
31,694,000
26,920,000
25,210,000
Operating expenses
Research development
6,728,000
6,728,000
6,706,000
5,692,000
5,530,000
Selling general and administrative
10,692,000
10,692,000
10,492,000
9,555,000
9,391,000
Total operating expenses
21,816,000
21,816,000
19,813,000
17,773,000
17,320,000
Operating income or loss
10,392,000
10,392,000
11,881,000
9,147,000
7,890,000
Interest expense
659,000
659,000
461,000
389,000
434,000
Total other income/expenses net
-2,600,000
-2,600,000
-1,171,000
-979,000
6,223,000
Income before tax
7,153,000
7,153,000
10,422,000
7,798,000
13,778,000
Income tax expense
1,602,000
1,602,000
2,006,000
1,558,000
1,807,000
Income from continuing operations
5,436,000
5,436,000
8,484,000
6,279,000
12,330,000
Net income
5,400,000
5,400,000
8,371,000
6,223,000
12,294,000
Net income available to common shareholders
5,400,000
5,400,000
8,371,000
6,223,000
12,294,000
Basic EPS
7.25
4.31
6.69
4.97
9.81
Diluted EPS
7.22
4.30
6.66
4.95
9.76
Basic average shares
1,251,750
1,251,700
1,251,900
1,252,500
1,253,600
Diluted average shares
1,253,860
1,256,400
1,256,900
1,257,900
1,260,100